Nonmetastatic CRPC: meeting an unmet need
Nonmetastatic castration-resistant prostate cancer (nmCRPC) is a disease which had no FDA-approved treatment. Following the completion of the Phase III SPARTAN trial (NCT01946204), a new nonsteroidal ...
Author: VJOncology
Added: 02/12/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts